These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37731453)

  • 1. Retraction: Synthesis of bioactive yttrium-metal-organic framework as efficient nanocatalyst in synthesis of novel pyrazolopyranopyrimidine derivatives and evaluation of anticancer activity.
    Frontiers Editorial Office
    Front Chem; 2023; 11():1285225. PubMed ID: 37731453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of Bioactive Yttrium-Metal-Organic Framework as Efficient Nanocatalyst in Synthesis of Novel Pyrazolopyranopyrimidine Derivatives and Evaluation of Anticancer Activity.
    Saleh RO; Achmad H; Daminov BT; Kzar HH; Mahdi AB; Hammid AT; Abid MK; Opulencia MJC; Mustafa YF; Sharma H
    Front Chem; 2022; 10():928047. PubMed ID: 35910741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retraction: Synthesis of efficient cobalt-metal organic framework as reusable nanocatalyst in the synthesis of new 1,4-dihydropyridine derivatives with antioxidant activity.
    Frontiers Editorial Office
    Front Chem; 2023; 11():1285183. PubMed ID: 37731455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retraction: Spectroscopic and molecular modeling studies of binding interaction between the new complex of yttrium and 1,10-phenanthroline derivatives with DNA and BSA.
    Frontiers Editorial Office
    Front Chem; 2024; 12():1433667. PubMed ID: 38835724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corrigendum: Green and Facile Synthesis of Metal-Organic Framework Cu-BTC-Supported Sn (II)-Substituted Keggin Heteropoly Composites as an Esterification Nanocatalyst for Biodiesel Production.
    Zhang Q; Ling D; Lei D; Wang J; Liu X; Zhang Y; Ma P
    Front Chem; 2020; 8():292. PubMed ID: 32373588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retraction: Design, synthesis, and biological evaluation of (E)-N'-((1-chloro-3,4-dihydronaphthalen-2-yl)methylene)benzohydrazide derivatives as anti-prostate cancer agents.
    Frontiers Editorial Office
    Front Chem; 2023; 11():1332615. PubMed ID: 38033470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retraction: Corrigendum: Design, synthesis, and biological evaluation of (E)-N'-((1-chloro-3,4-dihydronaphthalen-2-yl)methylene)benzohydrazide derivatives as anti-prostate cancer agents.
    Frontiers Editorial Office
    Front Chem; 2023; 11():1332618. PubMed ID: 38025054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retraction: Design and synthesis of magnetic Fe
    Ghamari Kargar P; Bagherzade G; Eshghi H
    RSC Adv; 2024 Jan; 14(3):1674. PubMed ID: 38187446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retraction of "Cu(II)-Containing Metal-Organic Framework with 1D Hexagonal Channels for Cyanosilylation Reaction and Anticancer Activity on Osteosarcoma Cells".
    Luo J; Ying LF; Zhang F; Zhou Z; Zhang YG
    ACS Omega; 2022 Mar; 7(10):9087. PubMed ID: 35309434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retraction: Experimental and theoretical investigations of Erbium complex: DNA/BSA interaction, anticancer and antibacterial studies.
    Frontiers Editorial Office
    Front Chem; 2024; 12():1433689. PubMed ID: 38855063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retraction: Taguchi-assisted optimization technique and density functional theory for green synthesis of a novel Cu-MOF derived from caffeic acid and its anticancerious activities.
    Frontiers Editorial Office
    Front Chem; 2023; 11():1285122. PubMed ID: 37731460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retraction: A green synthesis strategy of binuclear catalyst for the C-C cross-coupling reactions in the aqueous medium: Hiyama and Suzuki-Miyaura reactions as case studies.
    Frontiers Editorial Office
    Front Chem; 2023; 11():1181449. PubMed ID: 37082228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of novel Fe
    Bashar BS; Kareem HA; Hasan YM; Ahmad N; Alshehri AM; Al-Majdi K; Hadrawi SK; Al Kubaisy MMR; Qasim MT
    Front Chem; 2022; 10():1014731. PubMed ID: 36300031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retraction: Effect of bimetal element doping on the low-temperature activity of manganese-based catalysts for NH
    Frontiers Editorial Office
    Front Chem; 2023; 11():1208136. PubMed ID: 37228866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retraction: Electrospun Ta-MOF/PEBA nanohybrids and their CH
    Frontiers Editorial Office
    Front Chem; 2023; 11():1285227. PubMed ID: 37731454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retraction: Activated carbons from winemaking biowastes for electrochemical double-layer capacitors.
    Frontiers Editorial Office
    Front Chem; 2023; 11():1176163. PubMed ID: 36950454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copper-olsalazine metal-organic frameworks as a nanocatalyst and epigenetic modulator for efficient inhibition of colorectal cancer growth and metastasis.
    Li J; Zhang Z; Li J; Cun JE; Pan Q; Gao W; Luo K; He B; Gu Z; Pu Y
    Acta Biomater; 2022 Oct; 152():495-506. PubMed ID: 36087871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poly(aniline-
    Mirani Nezhad S; Pourmousavi SA; Nazarzadeh Zare E; Heidari G; Manoochehri H; Sharifi E
    Front Chem; 2022; 10():1046120. PubMed ID: 36385997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retraction:
    Frontiers Editorial Office
    Front Chem; 2024; 12():1433677. PubMed ID: 38855064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retraction: Studying the interaction between the new neodymium (Nd) complex with the ligand of 1,10-phenanthroline with FS-DNA and BSA.
    Frontiers Editorial Office
    Front Chem; 2024; 12():1433660. PubMed ID: 38841333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.